{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:06:58Z","timestamp":1758056818986,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.encep.2021.03.004","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T03:59:25Z","timestamp":1623988765000},"page":"280-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Variations immunologiques apr\u00e8s traitement d\u2019un \u00e9pisode maniaque"],"prefix":"10.1016","volume":"48","author":[{"given":"N.","family":"Halouani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Feki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ellouze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Turki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hachicha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Masmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Aribi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Aloulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.encep.2021.03.004_bib0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2013.02.001","article-title":"Prevalence, chronicity, burden and borders of bipolar disorder","volume":"148","author":"Fagiolini","year":"2013","journal-title":"J Affect Disorders"},{"issue":"2\u20133","key":"10.1016\/j.encep.2021.03.004_bib0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000356539","article-title":"The immunology of bipolar disorder","volume":"21","author":"Barbosa","year":"2014","journal-title":"Neuroimmunomodulation"},{"issue":"6","key":"10.1016\/j.encep.2021.03.004_bib0180","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00406-017-0847-1","article-title":"Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort","volume":"268","author":"Fond","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"6","key":"10.1016\/j.encep.2021.03.004_bib0185","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00004850-200511000-00002","article-title":"Effect of valproate on plasma levels of interleukin-6\u00a0in healthy male humans","volume":"20","author":"Shiah","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"issue":"11.","key":"10.1016\/j.encep.2021.03.004_bib0190","article-title":"Bipolar Disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications","volume":"7","author":"Rosenblat","year":"2017","journal-title":"Brain Sci"},{"issue":"1","key":"10.1016\/j.encep.2021.03.004_bib0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4306\/pi.2016.13.1.18","article-title":"Bipolar disorder: role of inflammation and the development of disease biomarkers","volume":"13","author":"Muneer","year":"2016","journal-title":"Psychiatry investigation"},{"issue":"2","key":"10.1016\/j.encep.2021.03.004_bib0200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1192\/bjp.164.2.251","article-title":"Changes of plasma concentrations of interleukin-1\u00a0alpha and interleukin-6\u00a0with neuroleptic treatment for schizophrenia","volume":"164","author":"Xu","year":"1994","journal-title":"Br J Psychiatry"},{"issue":"7","key":"10.1016\/j.encep.2021.03.004_bib0205","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1017\/S1461145710001410","article-title":"Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies","volume":"14","author":"Dean","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.encep.2021.03.004_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","article-title":"Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs","volume":"66","author":"Maes","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2021.03.004_bib0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jad.2017.10.027","article-title":"Systemic autoimmune diseases are associated with an increased risk of bipolar disorder: A nationwide population-based cohort study","volume":"227","author":"Wang","year":"2018","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1016\/j.encep.2021.03.004_bib0220","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1399-5618.2010.00853.x","article-title":"Autoimmune diseases, bipolar disorder, and non-affective psychosis","volume":"12","author":"Eaton","year":"2010","journal-title":"Bipolar Disord"},{"issue":"3","key":"10.1016\/j.encep.2021.03.004_bib0225","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/bdi.12159","article-title":"Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder","volume":"16","author":"Severance","year":"2014","journal-title":"Bipolar Disord"},{"issue":"1","key":"10.1016\/j.encep.2021.03.004_bib0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0924-9338(96)80459-7","article-title":"Antinuclear autoantibodies in relation to bipolar affective disorder and lithium therapy","volume":"11","author":"Spivak","year":"1996","journal-title":"Eur psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2021.03.004_bib0235","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hup.390","article-title":"Serological observations in patients suffering from acute manic episodes","volume":"17","author":"Wadee","year":"2002","journal-title":"Hum psychopharmacol"},{"issue":"1","key":"10.1016\/j.encep.2021.03.004_bib0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0300-483X(96)03594-9","article-title":"Current trends in drug-induced autoimmunity","volume":"119","author":"Uetrecht","year":"1997","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.encep.2021.03.004_bib0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0300-483X(96)03592-5","article-title":"Drug-induced autoimmunity: experience of the French pharmacovigilance system","volume":"119","author":"Vial","year":"1997","journal-title":"Toxicology"},{"issue":"9","key":"10.1016\/j.encep.2021.03.004_bib0250","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/1529-0131(200009)43:9<1994::AID-ANR10>3.0.CO;2-7","article-title":"Chlorpromazine induces apoptosis in activated human lymphoblasts: a mechanism supporting the induction of drug-induced lupus erythematosus?","volume":"43","author":"Hieronymus","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.encep.2021.03.004_bib0255","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-3956(99)00021-7","article-title":"Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis","volume":"33","author":"Haack","year":"1999","journal-title":"J Psychiatr Res"},{"issue":"3","key":"10.1016\/j.encep.2021.03.004_bib0260","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0006-3223(01)01144-1","article-title":"The effects of lithium on ex vivo cytokine production","volume":"50","author":"Rapaport","year":"2001","journal-title":"Biological psychiatry"},{"key":"10.1016\/j.encep.2021.03.004_bib0265","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jad.2016.06.016","article-title":"The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: a systematic review","volume":"203","author":"van den Ameele","year":"2016","journal-title":"J Affect Disord"},{"issue":"5","key":"10.1016\/j.encep.2021.03.004_bib0270","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-3223(94)00299-I","article-title":"Cytokine production in drug-free and neuroleptic-treated schizophrenic patients","volume":"38","author":"Bessler","year":"1995","journal-title":"Biol Psychiatr"},{"issue":"8","key":"10.1016\/j.encep.2021.03.004_bib0275","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.npp.1300756","article-title":"Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics","volume":"30","author":"Zhang","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.encep.2021.03.004_bib0280","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/09629350123895","article-title":"Serum IL-1beta, sIL-2R, IL-6, IL-8\u00a0and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment","volume":"10","author":"Erba\u011fci","year":"2001","journal-title":"Mediators Inflamm"},{"issue":"7","key":"10.1016\/j.encep.2021.03.004_bib0285","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0306-9877(81)90044-X","article-title":"A biochemical basis for the actions of lithium on behaviour and on immunity: relapsing and remitting disorders of inflammation and immunity such as multiple sclerosis or recurrent herpes as manic-depression of the immune system","volume":"7","author":"Horrobin","year":"1981","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.encep.2021.03.004_bib0290","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/1043-4666(91)90496-Z","article-title":"Lithium chloride potentiates tumor necrosis factor-induced and interleukin 1-induced cytokine and cytokine receptor expression","volume":"3","author":"Beyaert","year":"1991","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.encep.2021.03.004_bib0295","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/08923978909005388","article-title":"Sodium valproate does not alter immune competence in mice","volume":"11","author":"Brouland","year":"1989","journal-title":"Immunopharmacol immunotoxicol"},{"issue":"1\u20132","key":"10.1016\/j.encep.2021.03.004_bib0300","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6\u00a0and activation of NF-kappaB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.encep.2021.03.004_bib0305","doi-asserted-by":"crossref","first-page":"45266","DOI":"10.1038\/srep45266","article-title":"The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3\u00a0and HDAC3","volume":"7","author":"Ni","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.encep.2021.03.004_bib0310","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s10753-017-0574-9","article-title":"Anti-inflammatory effects of valproic acid in a rat model of renal ischemia\/reperfusion injury: alteration in cytokine profile","volume":"40","author":"Amirzargar","year":"2017","journal-title":"Inflammation"},{"issue":"10","key":"10.1016\/j.encep.2021.03.004_bib0315","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1046\/j.0953-816x.2001.01784.x","article-title":"Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus","volume":"14","author":"M\u00fcller","year":"2001","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1016\/j.encep.2021.03.004_bib0320","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","article-title":"Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Nery","year":"2008","journal-title":"Hum Psychopharmacol"},{"issue":"5","key":"10.1016\/j.encep.2021.03.004_bib0325","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.09m05117yel","article-title":"Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial","volume":"71","author":"Laan","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2021.03.004_bib0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2125.2003.01777.x","article-title":"A life-threatening interaction between lithium and celecoxib","volume":"55","author":"Sl\u00f8rdal","year":"2003","journal-title":"Br J Clin Pharmacol"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370062100124X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370062100124X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:40:18Z","timestamp":1757958018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001370062100124X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S001370062100124X"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2021.03.004","relation":{},"ISSN":["0013-7006"],"issn-type":[{"type":"print","value":"0013-7006"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variations immunologiques apr\u00e8s traitement d\u2019un \u00e9pisode maniaque","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2021.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}